Related content

Association between EML4-ALK fusion gene and thymidylate synthase mRNA expression in non-small cell lung cancer tissues

By                        

Experimental and Therapeutic Medicine, Vol. 9, Iss. 6, 2015-01 ,pp. : 2151-2154

Spandidos Publications

Access to resources Recommend Favorite

One-hour paclitaxel plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicentre, phase II trial

By Hainsworth J.D.   Urba W.J.   Hon J.K.   Thompson K.A.   Stagg M.P.   Hopkins L.G.   Thomas M.   Greco F.A.  

European Journal of Cancer, Vol. 34, Iss. 5, 1998-04 ,pp. : 654-658

Elsevier

Access to resources Recommend Favorite

Correlation between thymidylate synthase gene polymorphisms and efficacy of pemetrexed in advanced non-small cell lung cancer

By                  

Experimental and Therapeutic Medicine, Vol. 4, Iss. 6, 2012-01 ,pp. : 1010-1016

Spandidos Publications

Access to resources Recommend Favorite

Phase I study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small cell lung cancer (NSCLC)

By Ono Yasushi   Hino Mitsunori   Ueda Yuka   Kamizuru Ryoko   Omata Masatoshi   Uehara Takashi   Tanaka Yosuke   Soma Tomoyuki   Kudoh Shoji  

Medical Oncology, Vol. 24, Iss. 4, 2007-12 ,pp. : 402-406

Humana Press, Inc

Access to resources Recommend Favorite

Protective effect of amifostine against toxicity of paclitaxel and carboplatin in non-small cell lung cancer: A single center randomized study

By Kanat Ozkan   Evrensel Turkkan   Baran Ibrahim   Coskun Hakan   Zarifoglu Mehmet   Turan Omer   Kurt Ender   Demiray Mutlu   Gonullu Guzin   Manavoglu Osman  

Medical Oncology, Vol. 20, Iss. 3, 2003-09 ,pp. : 237-245

Humana Press, Inc

Access to resources Recommend Favorite